Influence of Lignocellulosic Waste Pre-Treatment on the Characteristics of Bond Rupture

by Štěpán Hýsek, Jaroslav Čermák, Martin Lexa
Published 2019-09-01

Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups

by Pavel Majek, Klara Pecankova, Jaroslav Cermak, Jan E. Dyr
Published 2015-01-01

Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome

by Klara Pecankova, Pavel Majek, Jaroslav Cermak, Jan E. Dyr
Published 2015-01-01

Proteome Changes in the Plasma of Myelodysplastic Syndrome Patients with Refractory Anemia with Excess Blasts Subtype 2

by Pavel Majek, Zuzana Riedelova-Reicheltova, Jiri Suttnar, Klara Pecankova, Jaroslav Cermak, Jan E. Dyr
Published 2014-01-01

Plasma Levels of Aminothiols, Nitrite, Nitrate, and Malondialdehyde in Myelodysplastic Syndromes in the Context of Clinical Outcomes and as a Consequence of Iron Overload

by Kristýna Pimková, Leona Chrastinová, Jiří Suttnar, Jana Štikarová, Roman Kotlín, Jaroslav Čermák, Jan Evangelista Dyr
Published 2014-01-01

Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients

by Hana Votavova, Zuzana Urbanova, David Kundrat, Michaela Dostalova Merkerova, Martin Vostry, Monika Hruba, Jaroslav Cermak, Monika Belickova
Published 2021-01-01

Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia...

by Michaela Dostalova Merkerova, Hana Remesova, Zdenek Krejcik, Nikoleta Loudova, Andrea Hrustincova, Katarina Szikszai, Jaroslav Cermak, Anna Jonasova, Monika Belickova
Published 2018-09-01

LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome

by Katarina Szikszai, Zdenek Krejcik, Jiri Klema, Nikoleta Loudova, Andrea Hrustincova, Monika Belickova, Monika Hruba, Jitka Vesela, Viktor Stranecky, David Kundrat, Pavla Pecherkova, Jaroslav Cermak, Anna Jonasova, Michaela Dostalova Merkerova
Published 2020-09-01

Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome

by Andrea Hrustincova, Zdenek Krejcik, David Kundrat, Katarina Szikszai, Monika Belickova, Pavla Pecherkova, Jiri Klema, Jitka Vesela, Monika Hruba, Jaroslav Cermak, Tereza Hrdinova, Matyas Krijt, Jan Valka, Anna Jonasova, Michaela Dostalova Merkerova
Published 2020-03-01

Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34⁺ Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients

by Pavla Koralkova, Monika Belickova, David Kundrat, Michaela Dostalova Merkerova, Zdenek Krejcik, Katarina Szikszai, Monika Kaisrlikova, Jitka Vesela, Pavla Vyhlidalova, Jan Stetka, Alzbeta Hlavackova, Jiri Suttnar, Patrik Flodr, Jan Stritesky, Anna Jonasova, Jaroslav Cermak, Vladimir Divoky
Published 2021-04-01

Clonal evolution in myelodysplastic syndromes

by Pedro da Silva-Coelho, Leonie I. Kroeze, Kenichi Yoshida, Theresia N. Koorenhof-Scheele, Ruth Knops, Louis T. van de Locht, Aniek O. de Graaf, Marion Massop, Sarah Sandmann, Martin Dugas, Marian J. Stevens-Kroef, Jaroslav Cermak, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Theo de Witte, Nicole M. A. Blijlevens, Petra Muus, Gerwin Huls, Bert A. van der Reijden, Seishi Ogawa, Joop H. Jansen
Published 2017-04-01